Literature DB >> 19995814

What can we learn from observational studies of oseltamivir to treat influenza in healthy adults?

Nick Freemantle1, Mel Calvert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19995814     DOI： 10.1136/bmj.b5248

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Oseltamivir Treatment for Influenza During the Flu Season of 2018-2019: A Longitudinal Study.

Authors:  Xiao-Guang Li; Jing Chen; Wei Wang; Fei Lin; Lu Li; Jing-Jin Liang; Zhong-Hua Deng; Bi-Ying Zhang; Ying Jia; Yuan-Bo Su; Yong-Feng Kang; Juan Du; Ya-Qiong Liu; Jie Xu; Qing-Bin Lu
Journal:  Front Microbiol       Date:  2022-05-10       Impact factor: 6.064

Review 2.  The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews.

Authors:  Barbara Michiels; Karolien Van Puyenbroeck; Veronique Verhoeven; Etienne Vermeire; Samuel Coenen
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

Review 3.  Influenza: Critique of the contemporary challenges for pandemic planning, prevention, control, and treatment in emergency health services.

Authors:  Jennifer R Patrick; Ramon Z Shaban; Gerry FitzGerald
Journal:  Australas Emerg Nurs J       Date:  2011-04-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.